Improving diabetes education with real-time glucose monitoring
Official title: Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes
Run by Scripps Whittier Diabetes Institute · NCT06296550 · Data updated 2026-11-12
This study is testing whether using a Continuous Glucose Monitoring device along with a text messaging program can help people with Type 2 Diabetes who don’t use insulin manage their condition better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Scripps Whittier Diabetes Institute Academic / other |
| Locations | 1 site (San Diego, California) |
| Status | Recruiting |
| Started | April 3, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT06296550 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with Type 2 Diabetes who are not using insulin therapy and have an A1c between 7.5% and 12.0%.
✕Probably not a fit
Patients currently using insulin therapies or those already utilizing a CGM device will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research investigates the effectiveness of adding Continuous Glucose Monitoring (CGM) devices to a text messaging diabetes education program for patients with Type 2 Diabetes who are not on insulin therapy. The study will last for 6 months and aims to enhance diabetes self-management by providing real-time insights into glycemic control. Participants will receive the Dulce Digital text messaging intervention alongside the CGM device, which is typically not available to non-insulin users. The goal is to assess the clinical and financial benefits of this combined approach.
Why it matters
Potential benefit: If successful, this study could significantly improve diabetes management and self-care for patients with Type 2 Diabetes.
How similar studies have gone: While the use of CGM devices in diabetes management is established, this specific approach of combining CGM with text messaging education for non-insulin users is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: * Are using insulin therapies * Are pregnant * Are currently using a CGM * Are currently participating in another diabetes-related study
Where it's running
-
Scripps Whittier Diabetes Institute
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Athena Philis-Tsimikas, MD — Scripps Health
- Study coordinator: Kallie Brown, PhD
- Email: brown.kallie@scrippshealth.org
- Phone: 858-258-3555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes
This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Perioperative Meditation Music for Type 2 Diabetes Patients Undergoing Elective Surgery
We’re testing whether playing self-selected meditation music around surgery helps adults with type 2 diabetes stay calm, sleep better, and keep blood sugar steadier.
-
How metformin works in people with or without the SLC16A11 risk variant
This study tests whether the SLC16A11 genetic variant changes how adults with type 2 diabetes respond to metformin over 6 months.
-
Remote-patient monitoring in diabetes care shows real-world outcomes
A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.